Background
Cardiac Pacemakers, Inc. (a Guidant subsidiary) held patents covering implantable cardioverter-defibrillators (ICDs) — devices implanted in patients with dangerous heart arrhythmias that continuously monitor heart rhythms and deliver life-saving electrical shocks when they detect a life-threatening arrhythmia. The patents covered both the detection algorithms and the therapeutic delivery systems used in ICDs. St. Jude Medical made competing ICDs and Cardiac Pacemakers sued for infringement.
Two primary issues arose on appeal: (1) whether the district court correctly construed the ICD claims under the doctrine of claim differentiation; and (2) en banc, whether § 271(f) — which extends infringement liability to supplying components from the United States for assembly abroad — applies to method patents or only to product/apparatus claims.
The Court’s Holding
On claim construction: the Federal Circuit affirmed the district court’s broader construction of the independent claims under the doctrine of claim differentiation. The doctrine provides that where an independent claim and a dependent claim differ, the independent claim must be broader — meaning the independent claim should not be construed to include a limitation that appears only in a dependent claim. St. Jude had argued for a narrowing construction that would have read dependent-claim limitations into the independent claim; the court rejected that argument and upheld the infringement finding based on the broader construction.
On the § 271(f) question — decided en banc — the court held that § 271(f) does not apply to method claims. The statute, by its terms, refers to supplying “components” of a patented invention for combination abroad. A method is a series of steps, not a physical component that can be supplied; accordingly, § 271(f) liability for overseas infringement does not extend to method patents. This aligned the Federal Circuit with other courts that had questioned the extraterritorial application of method patent infringement liability.
Key Takeaways
- Claim differentiation creates a presumption that independent claims are broader than their dependent claims — courts should not import into an independent claim a limitation that appears only in a dependent claim without compelling intrinsic evidence.
- Section 271(f)’s provision for liability arising from exporting components for foreign assembly applies only to apparatus and product claims, not to method claims — because method steps are not physical components that can be “supplied” for foreign combination.
- Medical device patent claims covering detection algorithms and therapeutic delivery methods are protectable as apparatus or method claims, but the form of the claim affects both infringement scope and extraterritorial reach.
- Patent drafters should include dependent claims that add specific preferred embodiment limitations — and should avoid claiming those limitations in the independent claims — to preserve maximum scope while documenting the preferred implementation.
Why It Matters
Cardiac Pacemakers v. St. Jude addressed two foundational principles of patent law — claim differentiation and extraterritorial infringement — in the context of high-stakes medical device litigation. The cardiac rhythm management market represents billions of dollars in annual sales and is dominated by a small number of companies with large, overlapping patent portfolios; disputes in this space routinely involve complex claim construction battles with major financial consequences.
The en banc holding on § 271(f) and method claims had broader significance beyond medical devices: it confirmed that businesses could design around U.S. method patents by conducting the patented process steps entirely abroad, without exposure to § 271(f) liability, even if the supporting hardware or components were shipped from the United States. This distinction has become increasingly significant as globally distributed manufacturing and service delivery have become standard operating models.